Breast cancer prevention - significant progress: 49% reduction in breast cancer occurrence with anastrozole (long-term follow up results of the IBIS II Prevention trial)

Breast cancer prevention – significant progress: 49% reduction in breast cancer occurrence with anastrozole (long-term follow up results of the IBIS II Prevention trial)

Breast international group (BIG) – aisbl

Rue de Bretagne 20,
1200 Brussels, Belgium
VAT BE 0468 176 240
IBAN BE08 0689 0916 0213

Donations greater than or equal to € 40 / year receive a 45% tax reduction. This means your donation of €40 only costs you € 22.

Navigation

The Breast International Group is proud to adhere
to the Code of Ethics of the VEF-AERF

Co-funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Health and Digital Executive Agency (HADEA). Neither the European Union nor the granting authority can be held responsible for them.

Breast international group (BIG) - aisbl